Literature DB >> 19995225

Analysis of FLT3-ITD and FLT3-Asp835 mutations in de novo acute myeloid leukemia: evaluation of incidence, distribution pattern, correlation with cytogenetics and characterization of internal tandem duplication from Indian population.

Firoz Ahmad1, Swarna Mandava, Bibhu Ranjan Das.   

Abstract

Mutation of the FMS-like tyrosine kinase 3 (FLT3) gene in Indian population remains unclear till date. Here, we found FLT3-ITD mutations in 19.1%, FLT3-Asp835 mutations in 4.7%, and dual mutations in 4.2%, accounting for overall mutation in 28% of acute myeloid leukemia (AML) patients. FLT3 mutation was more prevalent in APL than non-APL patients (32.2% vs 26.3%), adults tend to show higher incidence than children (30.6% vs 18.2%, p = .1), and were significantly associated with normal karyotype, high WBCs, with no specific distribution in FAB subtypes. Notably, FLT3 mutation was present in 50% of patients with NPM1-Mt, when compared to only 22.6% of patients with NPM1-wt (p < .001). Sequence analyses of internal tandem duplications (ITDs) revealed that duplications were mostly restricted to JM domain (3 to 165 nucleotides). Interestingly, 92.3% cases showed duplication of at least one amino acid (AA) within the stretch Y589 to K602 that includes the two SH2-binding motifs. Analysis of frequency of single AA in the duplicated region revealed that E598 was the most frequently duplicated single AA in 72%, followed by R595 (69.2%), and Y599 (66.7%). Finally, three types of point mutations were identified, including D835Y, D835H, and D835A.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19995225     DOI: 10.3109/07357900903095649

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  5 in total

1.  High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in FLT3 internal tandem duplication (ITD) negative patients in adult acute myeloid leukaemia: A prospective pilot study from India.

Authors:  Surender Kumar Sharawat; Vinod Raina; Lalit Kumar; Atul Sharma; Radhika Bakhshi; Sreenivas Vishnubhatla; Ritu Gupta; Sameer Bakhshi
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

2.  FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand

Authors:  Piyanan Mevatee; Adisak Tantiworawit; Patrinee Traisathit; Chaniporn Puaninta; Umnat Mevatee; Sirinda Angsuchawan; Kanokkan Bumroongkit
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

3.  Two Novel Mutations of the NPM1 Gene in Syrian Adult Patients with Acute Myeloid Leukemia and Normal Karyotype.

Authors:  Ismael F Alarbeed; Abdulsamad Wafa; Faten Moassass; Bassel Al-Halabi; Walid Alachkar; Imad Aboukhamis
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

4.  Prognostic Relevance of DNMT3A, FLT3 and NPM1 Mutations in Syrian Acute Myeloid Leukemia Patients.

Authors:  Yahia Moualla; Faten Moassass; Bassel Al-Halbi; Walid Al-Achkar; Michael Georgeos; Haissam Yazigi; Atieh Khamis
Journal:  Asian Pac J Cancer Prev       Date:  2022-04-01

5.  Multiplex Approach in Classification, Diagnosis, and Prognostication in Acute Myeloid Leukemia: An Experience from Tertiary Cancer Center in South India.

Authors:  Rachna Khera; Faiq Ahmed; Manasi Chetan Mundada; Sandhya G Devi; Sudha S Murthy; Nambaru Lavanya; Senthil J Rajappa; Krishna Mohan Mallavarapu; A Santa
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.